what are the serious side effects of glp 1 Overdose risks increase as demand for injectable weight-loss drugs on rise, research finds GLP-1 drugs can cause pancreatitis,

Stringent cost and payer controls are a significant restraint in the GLP-1 drugs market due to the high prices associated with these therapies

As a result, future obesity management is likely to prioritize integrated approaches that combine pharmacotherapy with lifestyle interventions, rather than replacing lifestyle changes with medication alone

doi:10.1038/2031068a0

Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis

Hng dn s dng vin ung trng da Now Ung 1 vin/ngy

Liraglutide may reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults at lower doses and can improve cardiovascular health metrics and insulin resistance